Mayuko Nakakoji

发表

Practice patterns and outcomes for triple-class exposed patients with relapsed/refractory multiple myeloma in Japan.

S. Iida, D. Spanopoulos, T. Ishida, 2022, Future Oncology.

Evaluating process utilities for the treatment burden of chemotherapy in multiple myeloma in Japan: a time trade-off valuation study.

S. Iida, T. Ishida, T. Murata, 2023, Journal of medical economics.